Compare First Citizens BancShares Inc (FCNCA) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs Stryker Corporation — how do they compare? First Citizens BancShares Inc trades at $2,162.83 (market cap $23.76B), while Stryker Corporation trades at $329.57 (market cap $121.31B). The key difference: Stryker Corporation is far larger — about 5.1× First Citizens BancShares Inc's market cap, and Stryker Corporation pays the higher dividend (1.11%). Which is the better fit depends on your goals.
| FCNCA | SYK | |
|---|---|---|
Market Cap | $23.76B | $121.31B |
Sector | Sector/Thematic | Technology |
52-Week High | $2.20K | $403.53 |
52-Week Low | $1.64K | $282.58 |
Dividend Yield | 0.41% | 1.11% |
Enterprise Value | — | $133.07B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Citizens BancShares (FCNCA) trades at $2,166.64, up 5.06% today, with a neutral technical signal and bullish moving averages. The company reported strong Q1 2026 earnings of $44.86 per share, beating estimates, and maintains a solid net income margin of 24.35%. Recent news includes a planned rebranding of Silicon Valley Bank and expansion of commercial banking capabilities.
Outlook remains stable with consistent revenue near $9.3B and profit growth. Risks include margin pressure and credit trends, but analyst consensus is a $2,320 price target with a hold-heavy rating. The stock presents a value opportunity with a low P/E of 11.94, though investor sentiment is cautious amid sector challenges.
Stryker (SYK) trades at $329.38, up 5.84% in the last session, yet technical indicators signal a bearish trend. The company reported a Q1 2026 earnings miss due to a temporary cyber disruption but maintained full-year guidance, with strong profitability margins and robust cash flow. Recent news highlights expansion of its Mako robotics platform, reinforcing its innovation-led growth strategy in the medical technology sector.
The investment outlook is positive based on strong fundamentals and analyst consensus, but near-term risks include competitive pressures and execution challenges. With a consensus price target of $388.44 representing ~18% upside, the stock offers value for long-term investors, though volatility may persist until Q2 earnings clarify the post-disruption recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
